Mortality Rate in Acute Mesenteric Ischemia
The mortality rate for acute mesenteric ischemia (AMI) remains approximately 50-60%, with untreated cases approaching 50% and overall in-hospital mortality ranging from 50-62.5% even with treatment. 1
Current Mortality Statistics
According to the most recent 2022 World Society of Emergency Surgery guidelines, if untreated, mortality remains in the range of 50%, and even with prompt diagnosis and intervention, mortality rates exceed 50% 1. This represents a persistently lethal condition despite advances in diagnosis and treatment.
Contemporary Data from Recent Studies
The most recent high-quality evidence shows:
- Overall in-hospital mortality: 50-62.5% 2, 3, 4
- A 2025 retrospective cohort from tertiary centers reported 50% in-hospital mortality, with most deaths occurring in the first postoperative week 2
- A 2022 systematic review and meta-analysis found overall short-term mortality of 59.6% (95% CI 55.5-63.6) 5
Temporal Trends
There has been modest improvement over time: mortality decreased from 68.7% in patients treated before 2000 to 55.0% in patients treated from 2000 onwards (p<0.05) 5. This improvement likely reflects earlier diagnosis with modern CT angiography and the advent of endovascular revascularization techniques 1.
Mortality by Etiology and Treatment
By Underlying Cause
- Occlusive arterial AMI (most common, 68.6% of cases): Higher mortality, particularly with thrombosis 5
- Mesenteric venous thrombosis: Significantly lower mortality at 24.6% (95% CI 17.0-32.9) 5
- Non-occlusive mesenteric ischemia (NOMI): 58.4% mortality (95% CI 48.6-67.7) 5
Impact of Revascularization
When occlusive arterial AMI is successfully revascularized, short-term mortality drops to 33.9% (95% CI 30.7-37.4) 5. This represents a substantial improvement compared to non-revascularized cases and underscores the critical importance of early diagnosis and intervention.
Long-Term Survival
Five-year survival post-discharge is 74.8%, with most deaths occurring within the first 12 months 2. Mid/long-term mortality overall reaches 68.2% (95% CI 60.7-74.9) 5. Sepsis is the leading cause of death post-discharge, followed by cardiovascular disease 2.
Key Predictors of Mortality
Independent Risk Factors
The following factors independently predict death:
- Advanced age (OR 1.077 per year) 3, 2, 4
- Metabolic acidosis (OR 6.604) 3
- Elevated blood urea nitrogen (OR 7.219) 3
- Bandemia (OR 3.894) 3
- Elevated AST (OR 4.532) 3
- Heart failure 4
- Higher white blood cell count 4
- Elevated creatinine 2, 6
- Arterial thrombosis as etiology (vs. embolism) 2
- Extensive bowel resection 2, 7, 6
- Large bowel involvement (100% mortality in one series) 7
- Pneumatosis intestinalis on CT 2
- Peritonitis at presentation (OR 9.4) 8
- Bowel necrosis (OR 10.4) 8
Clinical Scoring Systems
The Mannheim Peritonitis Index (MPI) and APACHE-II score are the best predictors of in-hospital death 9. When combined, they achieve an AUC of 0.897, with MPI showing an adjusted OR of 1.14 per point increase 9.
Critical Clinical Pitfalls
The fundamental problem is delayed diagnosis: 63% of patients present more than 24 hours after symptom onset 8, and 81% already have intestinal necrosis at the time of surgery 8. This delay is the primary driver of the persistently high mortality.
High-risk patients are frequently under-recognized: 46% of patients had prior conditions placing them at high risk for AMI, including chronic mesenteric ischemia (26 patients) and inadequately anticoagulated chronic atrial fibrillation (9 patients) 8. These patients require heightened vigilance and lower threshold for advanced imaging.
Sepsis when it develops carries grave prognosis: The presence of septic syndrome, vasopressor requirement, and systemic complications dramatically increases mortality 3, 7, 4. Anticoagulation therapy is negatively correlated with mortality risk, while vasopressor use is positively correlated 4.